Records containing: Hidradenitis Suppurativa
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2021-08-02Intralesional Diode Laser Treatment of Fistulas in Hidradenitis Suppurativa: Protocol for a Within-person Randomised Trial
-
CLINICAL_TRIALS study record update · 2021-06-14A Phase 2, Multicenter, Randomized, Placebo-Controlled, Double-Blind, Proof-of-Concept Study to Evaluate Guselkumab for the Treatment of Subjects With Moderate to Severe Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2021-06-04Linking Epidermal Barrier Function With Anti-Oxidant Defense Mechanisms in Skin Conditions
-
CLINICAL_TRIALS study record update · 2021-04-13Non-interventional Study to Evaluate Cutaneous and Circulating Inflammatory Biomarkers for a Novel IRAK4-targeted Therapeutic in Hidradenitis Suppurativa and Atopic Dermatitis Patient Samples
-
CLINICAL_TRIALS study record update · 2020-10-01Evaluating the Effect of a Written Action Plan on Comfort and Understanding of Hidradenitis Suppurativa
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-09-21A Phase 2, Dose-Escalation, Placebo-Controlled Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2020-09-04An Alternative Dose Interval Study to Examine Safety and Identify Potential Biomarkers in Participants With Hidradenitis Suppurativa Receiving Brodalumab
-
CLINICAL_TRIALS study record update · 2020-06-05A Pilot Study to Examine Safety, Activity and Biomarkers in Participants With Hidradenitis Suppurativa Receiving a Previously Tested Subcutaneous Dose of Anti-IL-23 Monoclonal Antibody Guselkumab.
-
CLINICAL_TRIALS study record update · 2020-06-04A Pilot Study of Safety and Biomarkers In Hidradenitis Suppurativa Participants Receiving Brodalumab
-
CLINICAL_TRIALS study record update · 2020-05-20A Phase 2, Open-Label, Single-Arm Study of the Safety of INCB054707 in Participants With Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2020-03-25A Phase I, Randomized, Open-label, Parallel-group Study to Determine the Pharmacokinetics, Safety, and Tolerability of MSB11022 (Proposed Adalimumab Biosimilar) Following a Single Subcutaneous Injection by an Auto-injector or by a Pre-filled Syringe in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2020-03-24Pilot Study of Hydroxychloroquine for the Treatment of Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2020-01-09Effectiveness of Adalimumab in Moderate to Severe HidrAdenitis SuppuRativa Patients - a Multi cOuNtry studY in Real Life Setting - HARMONY Study
-
CLINICAL_TRIALS study record update · 2019-08-30Safety and Efficacy of Er:YAG and Nd:YAG Laser Therapy in Gynecology: A Retrospective Case Series.
-
CLINICAL_TRIALS study record update · 2019-08-09Post Marketing Observational Study to Assess Quality of Life Changes in Swedish Patients With Moderate or Severe Hidradenitis Suppurativa (HS) After 6 Months on Adalimumab Treatment (HOPE Study)
-
CLINICAL_TRIALS study record update · 2019-06-03Open-label, Investigator-Initiated, Single Site Exploratory Trial Evaluating Cosentyx (Secukinumab) for Patients With Moderate-to-Severe Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2019-04-10An Open-label Single Center Study to Evaluate the Efficacy of SILIQ™ (Brodalumab) for the Treatment of Moderate Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2019-04-02A Phase 2 Open-label Single Center Study to Evaluate the Efficacy of Apremilast for the Treatment of Moderate Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2019-02-27A Phase 3 Multicenter, Open-label, Single Arm Study of the Safety and Efficacy of Adalimumab in Japanese Subjects With Moderate to Severe Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2019-02-08Cost-effectiveness of Adalimumab With Adjuvant Surgery Versus Adalimumab Monotherapy in the Treatment of Hidradenitis Suppurativa'
-
CLINICAL_TRIALS study record update · 2018-10-25Randomized Double Blind Placebo Controlled Pilot Study on Botulinum Toxin B as Treatment for Hidradenitis Suppurativa
-
CLINICAL_TRIALS study record update · 2018-09-25Role of Nutritionist in the Multidisciplinary Approach of Hidradenitis Suppurativa (Acne Inversa)
-
CLINICAL_TRIALS study record update · 2018-09-13Association Between Hidradenitis Suppurativa and Spondyloarthritis
-
CLINICAL_TRIALS study record update · 2018-07-26Relationship Between Hidradenitis Suppurativa and Periodontal Diseases
-
CLINICAL_TRIALS study record update · 2018-07-24Short-term Safety, Efficacy and Mode of Action of Apremilast in Moderate Suppurative Hidradenitis: A Randomised Double-blind Placebo Controlled Trial